)
Visual
test
SyntheticMR
SyntheticMR (SYNT) investor relations material
SyntheticMR Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary6 Feb, 2026
Executive summary
Net sales for Q4 2025 rose 42% year-over-year to 18.0 million SEK, with full-year sales up 2% to 57.0 million SEK.
Operating profit improved in Q4 to -5.3 million SEK from -7.5 million SEK, but full-year operating loss widened to -49.3 million SEK, mainly due to impairments and acquisition costs.
Adjusted full-year operating loss (excluding impairments and acquisition costs) was -30.5 million SEK.
Cash and cash equivalents at year-end were 7.4 million SEK, down from 51.0 million SEK the previous year.
Major regulatory approvals were achieved in India, Europe, Japan, and South Korea for key products.
Financial highlights
Q4 net sales: 17,984 TSEK (up 42% YoY); full-year net sales: 57,048 TSEK (up 2% YoY).
Q4 operating margin: -30% (improved from -59% YoY); full-year operating margin: -86% (down from -33%).
Q4 net loss: -5,989 TSEK; full-year net loss: -54,927 TSEK.
Earnings per share before dilution: -0.12 SEK in Q4, -0.97 SEK for the year.
Cash flow from operating activities: -4,259 TSEK in Q4, -5,472 TSEK for the year.
Outlook and guidance
Focus on achieving profitability without further capital injections through commercial execution, recurring revenue growth, and cost discipline.
Strategic priority to return to growth in the U.S. market.
Long-term growth prospects supported by structural shifts in healthcare, especially in Alzheimer's monitoring.
Clarify full-year APAC revenue decline vs Q4 strength
Detail path to profitability given current cash burn
US market strategy shift: expected revenue impact?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebPROV
Q2 FY2026 net income rose 65% year-over-year, with higher margins and strong credit quality. - 6 FebNVDA
AI-driven digital twins and accelerated computing are set to revolutionize industrial design and manufacturing. - 6 FebCDP
2025 FFO/share rose 5.8% to $2.72, with strong leasing and investment; 2026 guidance signals more growth. - 6 FebPECO
2026 FFO per share growth guided at 5.5% with record occupancy and robust acquisitions. - 6 FebCRI
Q1 2025 saw record revenue, a return to profit, and major new contracts in space technology. - 6 FebCRINet loss widened to 7.5m PLN in H1 2024 as revenue fell and R&D costs remained high.
- 6 FebCRINet loss deepened on lower sales and higher costs, but major new contracts and restructuring are underway.
- 6 FebEMBASSY
Record revenue, NOI, and distributions highlight strong growth and robust segment performance. - 6 FebCRIRevenue fell and losses deepened, but ESA contracts and R&D projects drive future prospects.
- 6 FebTUPRS
Net income reached TRY 29.5 billion, with strong dividends and a robust net cash position.
Next SyntheticMR earnings date
Q1 202612 May, 2026
SyntheticMR
Next SyntheticMR earnings date
Q1 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
SyntheticMR's innovative software products for MRI shorten exam times and enable more information to be extracted from the images. These benefits create a better patient experience, reducing the time spent in the noisy, claustrophobic bore of the scanner. The company's customers across the globe are realizing cost savings in both their daily clinical workflow, as well as their yearly budgets. SyntheticMR's products manage a wide variety of exams such as Cardiac MRI, Breast MRI and Body MRI, with applications in Cardiology, Neurosurgery and Oncology.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage